nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBA4A—Vincristine—kidney cancer	0.298	0.377	CbGbCtD
Podofilox—TUBB—Paclitaxel—kidney cancer	0.132	0.167	CbGbCtD
Podofilox—TUBB—Vinblastine—kidney cancer	0.116	0.146	CbGbCtD
Podofilox—TUBB—Vincristine—kidney cancer	0.114	0.144	CbGbCtD
Podofilox—TOP2A—Doxorubicin—kidney cancer	0.0379	0.0479	CbGbCtD
Podofilox—CYP3A4—Everolimus—kidney cancer	0.0243	0.0307	CbGbCtD
Podofilox—CYP3A4—Temsirolimus—kidney cancer	0.0164	0.0207	CbGbCtD
Podofilox—CYP2C19—Sorafenib—kidney cancer	0.0103	0.0131	CbGbCtD
Podofilox—CYP3A4—Pazopanib—kidney cancer	0.00862	0.0109	CbGbCtD
Podofilox—CYP3A4—Erlotinib—kidney cancer	0.00615	0.00777	CbGbCtD
Podofilox—CYP3A4—Paclitaxel—kidney cancer	0.00563	0.00712	CbGbCtD
Podofilox—Balanoposthitis—Capecitabine—kidney cancer	0.00505	0.0438	CcSEcCtD
Podofilox—CYP3A4—Sorafenib—kidney cancer	0.005	0.00632	CbGbCtD
Podofilox—CYP3A4—Vinblastine—kidney cancer	0.00494	0.00624	CbGbCtD
Podofilox—CYP3A4—Vincristine—kidney cancer	0.00485	0.00614	CbGbCtD
Podofilox—CYP2C19—urine—kidney cancer	0.0041	0.121	CbGeAlD
Podofilox—CYP3A4—Sunitinib—kidney cancer	0.00405	0.00512	CbGbCtD
Podofilox—Wound secretion—Capecitabine—kidney cancer	0.00365	0.0317	CcSEcCtD
Podofilox—Skin papilloma—Everolimus—kidney cancer	0.00353	0.0306	CcSEcCtD
Podofilox—NR3C1—urine—kidney cancer	0.0032	0.0948	CbGeAlD
Podofilox—CYP3A4—Doxorubicin—kidney cancer	0.00303	0.00384	CbGbCtD
Podofilox—TUBA4A—nephron tubule—kidney cancer	0.00254	0.0751	CbGeAlD
Podofilox—CYP3A4—urine—kidney cancer	0.00242	0.0717	CbGeAlD
Podofilox—TUBA4A—renal system—kidney cancer	0.00231	0.0683	CbGeAlD
Podofilox—TUBA4A—kidney—kidney cancer	0.00223	0.066	CbGeAlD
Podofilox—TUBA4A—cortex of kidney—kidney cancer	0.00217	0.0643	CbGeAlD
Podofilox—TUBA4A—gonad—kidney cancer	0.00207	0.0612	CbGeAlD
Podofilox—TUBA4A—cardiac atrium—kidney cancer	0.00207	0.0612	CbGeAlD
Podofilox—Etoposide—GSTT1—kidney cancer	0.00204	0.372	CrCbGaD
Podofilox—Localized exfoliation—Capecitabine—kidney cancer	0.00197	0.0171	CcSEcCtD
Podofilox—Skin ulcer—Pazopanib—kidney cancer	0.00187	0.0162	CcSEcCtD
Podofilox—TUBB—nephron tubule—kidney cancer	0.00186	0.0551	CbGeAlD
Podofilox—Scab—Capecitabine—kidney cancer	0.00167	0.0145	CcSEcCtD
Podofilox—Skin discolouration—Pazopanib—kidney cancer	0.00161	0.014	CcSEcCtD
Podofilox—Etoposide—GSTP1—kidney cancer	0.00161	0.294	CrCbGaD
Podofilox—TUBB—cortex of kidney—kidney cancer	0.00159	0.0471	CbGeAlD
Podofilox—Blister—Erlotinib—kidney cancer	0.00154	0.0134	CcSEcCtD
Podofilox—TUBB—cardiac atrium—kidney cancer	0.00151	0.0448	CbGeAlD
Podofilox—Skin exfoliation—Pazopanib—kidney cancer	0.00139	0.0121	CcSEcCtD
Podofilox—Blister—Sunitinib—kidney cancer	0.00133	0.0116	CcSEcCtD
Podofilox—Swelling—Temsirolimus—kidney cancer	0.00127	0.011	CcSEcCtD
Podofilox—Tenderness—Erlotinib—kidney cancer	0.00127	0.011	CcSEcCtD
Podofilox—Inflammation—Everolimus—kidney cancer	0.00119	0.0103	CcSEcCtD
Podofilox—Dermatitis bullous—Temsirolimus—kidney cancer	0.00117	0.0102	CcSEcCtD
Podofilox—Inflammation—Erlotinib—kidney cancer	0.00114	0.00993	CcSEcCtD
Podofilox—Skin exfoliation—Everolimus—kidney cancer	0.0011	0.00953	CcSEcCtD
Podofilox—Skin discolouration—Sunitinib—kidney cancer	0.00106	0.00923	CcSEcCtD
Podofilox—Skin exfoliation—Erlotinib—kidney cancer	0.00106	0.0092	CcSEcCtD
Podofilox—Dry skin—Temsirolimus—kidney cancer	0.00103	0.00893	CcSEcCtD
Podofilox—TUBA4A—Temsirolimus—Everolimus—kidney cancer	0.00102	0.173	CbGdCrCtD
Podofilox—TUBA4A—Sirolimus—Everolimus—kidney cancer	0.00102	0.173	CbGdCrCtD
Podofilox—TUBA4A—Sirolimus—Temsirolimus—kidney cancer	0.00102	0.173	CbGdCrCtD
Podofilox—TUBA4A—Gefitinib—Erlotinib—kidney cancer	0.00102	0.173	CbGdCrCtD
Podofilox—Dry skin—Pazopanib—kidney cancer	0.000969	0.00841	CcSEcCtD
Podofilox—Ulcer—Dactinomycin—kidney cancer	0.000961	0.00835	CcSEcCtD
Podofilox—Redness—Paclitaxel—kidney cancer	0.000956	0.0083	CcSEcCtD
Podofilox—Skin exfoliation—Sorafenib—kidney cancer	0.000953	0.00828	CcSEcCtD
Podofilox—Skin exfoliation—Sunitinib—kidney cancer	0.000917	0.00796	CcSEcCtD
Podofilox—Etoposide—PTGS1—kidney cancer	0.000891	0.163	CrCbGaD
Podofilox—Tenderness—Gemcitabine—kidney cancer	0.000883	0.00767	CcSEcCtD
Podofilox—NR3C1—nephron tubule—kidney cancer	0.000862	0.0255	CbGeAlD
Podofilox—Dermatitis bullous—Erlotinib—kidney cancer	0.000843	0.00732	CcSEcCtD
Podofilox—Skin ulcer—Paclitaxel—kidney cancer	0.000829	0.0072	CcSEcCtD
Podofilox—Haematuria—Temsirolimus—kidney cancer	0.000824	0.00716	CcSEcCtD
Podofilox—Ulcer—Gemcitabine—kidney cancer	0.000815	0.00708	CcSEcCtD
Podofilox—Tingling sensation—Paclitaxel—kidney cancer	0.000803	0.00697	CcSEcCtD
Podofilox—NR3C1—renal system—kidney cancer	0.000783	0.0232	CbGeAlD
Podofilox—Haematuria—Pazopanib—kidney cancer	0.000777	0.00675	CcSEcCtD
Podofilox—Dry skin—Everolimus—kidney cancer	0.000765	0.00664	CcSEcCtD
Podofilox—NR3C1—kidney—kidney cancer	0.000757	0.0224	CbGeAlD
Podofilox—Tenderness—Paclitaxel—kidney cancer	0.00074	0.00642	CcSEcCtD
Podofilox—Dry skin—Erlotinib—kidney cancer	0.000738	0.00641	CcSEcCtD
Podofilox—NR3C1—cortex of kidney—kidney cancer	0.000738	0.0218	CbGeAlD
Podofilox—Skin exfoliation—Gemcitabine—kidney cancer	0.000736	0.00639	CcSEcCtD
Podofilox—Haemoglobin—Pazopanib—kidney cancer	0.000735	0.00638	CcSEcCtD
Podofilox—Blister—Capecitabine—kidney cancer	0.000735	0.00638	CcSEcCtD
Podofilox—Haemorrhage—Pazopanib—kidney cancer	0.000731	0.00635	CcSEcCtD
Podofilox—Dermatitis bullous—Sunitinib—kidney cancer	0.000729	0.00633	CcSEcCtD
Podofilox—Skin discolouration—Paclitaxel—kidney cancer	0.000714	0.0062	CcSEcCtD
Podofilox—NR3C1—gonad—kidney cancer	0.000702	0.0208	CbGeAlD
Podofilox—NR3C1—cardiac atrium—kidney cancer	0.000702	0.0208	CbGeAlD
Podofilox—Immune system disorder—Temsirolimus—kidney cancer	0.000701	0.00609	CcSEcCtD
Podofilox—Skin ulcer—Capecitabine—kidney cancer	0.00068	0.00591	CcSEcCtD
Podofilox—Erythema—Temsirolimus—kidney cancer	0.000676	0.00587	CcSEcCtD
Podofilox—Dry skin—Sorafenib—kidney cancer	0.000664	0.00577	CcSEcCtD
Podofilox—Tingling sensation—Capecitabine—kidney cancer	0.000659	0.00572	CcSEcCtD
Podofilox—Dry skin—Sunitinib—kidney cancer	0.000639	0.00555	CcSEcCtD
Podofilox—Erythema—Pazopanib—kidney cancer	0.000637	0.00553	CcSEcCtD
Podofilox—Skin exfoliation—Paclitaxel—kidney cancer	0.000616	0.00535	CcSEcCtD
Podofilox—Haematuria—Everolimus—kidney cancer	0.000613	0.00533	CcSEcCtD
Podofilox—CYP3A4—renal system—kidney cancer	0.000592	0.0175	CbGeAlD
Podofilox—Skin discolouration—Capecitabine—kidney cancer	0.000586	0.00509	CcSEcCtD
Podofilox—Dermatitis bullous—Gemcitabine—kidney cancer	0.000585	0.00508	CcSEcCtD
Podofilox—Haemoglobin—Vinblastine—kidney cancer	0.000583	0.00506	CcSEcCtD
Podofilox—Haemoglobin—Everolimus—kidney cancer	0.00058	0.00504	CcSEcCtD
Podofilox—Haemorrhage—Vinblastine—kidney cancer	0.00058	0.00503	CcSEcCtD
Podofilox—Haemorrhage—Everolimus—kidney cancer	0.000577	0.00501	CcSEcCtD
Podofilox—CYP3A4—kidney—kidney cancer	0.000573	0.017	CbGeAlD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.000571	0.00496	CcSEcCtD
Podofilox—Haemoglobin—Erlotinib—kidney cancer	0.00056	0.00486	CcSEcCtD
Podofilox—Ulcer—Capecitabine—kidney cancer	0.00056	0.00486	CcSEcCtD
Podofilox—Haemorrhage—Erlotinib—kidney cancer	0.000557	0.00484	CcSEcCtD
Podofilox—Oedema—Temsirolimus—kidney cancer	0.000552	0.00479	CcSEcCtD
Podofilox—Inflammation—Capecitabine—kidney cancer	0.000546	0.00474	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.000538	0.00467	CcSEcCtD
Podofilox—Skin disorder—Temsirolimus—kidney cancer	0.000536	0.00465	CcSEcCtD
Podofilox—Swelling—Paclitaxel—kidney cancer	0.000531	0.00461	CcSEcCtD
Podofilox—Immune system disorder—Everolimus—kidney cancer	0.000522	0.00453	CcSEcCtD
Podofilox—Oedema—Pazopanib—kidney cancer	0.00052	0.00451	CcSEcCtD
Podofilox—Etoposide—PTGS2—kidney cancer	0.000509	0.0929	CrCbGaD
Podofilox—Redness—Doxorubicin—kidney cancer	0.000506	0.00439	CcSEcCtD
Podofilox—Skin exfoliation—Capecitabine—kidney cancer	0.000506	0.00439	CcSEcCtD
Podofilox—Skin disorder—Pazopanib—kidney cancer	0.000505	0.00438	CcSEcCtD
Podofilox—Haemoglobin—Sorafenib—kidney cancer	0.000504	0.00437	CcSEcCtD
Podofilox—Erythema—Everolimus—kidney cancer	0.000503	0.00437	CcSEcCtD
Podofilox—Haemorrhage—Sorafenib—kidney cancer	0.000501	0.00435	CcSEcCtD
Podofilox—Insomnia—Temsirolimus—kidney cancer	0.000499	0.00433	CcSEcCtD
Podofilox—Erythema—Erlotinib—kidney cancer	0.000485	0.00421	CcSEcCtD
Podofilox—Haemoglobin—Sunitinib—kidney cancer	0.000485	0.00421	CcSEcCtD
Podofilox—Haemorrhage—Sunitinib—kidney cancer	0.000482	0.00419	CcSEcCtD
Podofilox—Blister—Doxorubicin—kidney cancer	0.000474	0.00411	CcSEcCtD
Podofilox—Pain—Temsirolimus—kidney cancer	0.000472	0.0041	CcSEcCtD
Podofilox—Insomnia—Pazopanib—kidney cancer	0.00047	0.00408	CcSEcCtD
Podofilox—Paraesthesia—Pazopanib—kidney cancer	0.000467	0.00405	CcSEcCtD
Podofilox—Immune system disorder—Sorafenib—kidney cancer	0.000453	0.00393	CcSEcCtD
Podofilox—Pain—Pazopanib—kidney cancer	0.000444	0.00386	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—kidney cancer	0.000438	0.00381	CcSEcCtD
Podofilox—Erythema—Sorafenib—kidney cancer	0.000436	0.00379	CcSEcCtD
Podofilox—Swelling—Capecitabine—kidney cancer	0.000436	0.00378	CcSEcCtD
Podofilox—Immune system disorder—Sunitinib—kidney cancer	0.000436	0.00378	CcSEcCtD
Podofilox—Etoposide—ABCB1—kidney cancer	0.000433	0.079	CrCbGaD
Podofilox—Dry skin—Paclitaxel—kidney cancer	0.000429	0.00373	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000425	0.00369	CcSEcCtD
Podofilox—Stinging—Doxorubicin—kidney cancer	0.000421	0.00366	CcSEcCtD
Podofilox—Erythema—Sunitinib—kidney cancer	0.00042	0.00365	CcSEcCtD
Podofilox—Haematuria—Gemcitabine—kidney cancer	0.000411	0.00357	CcSEcCtD
Podofilox—Oedema—Everolimus—kidney cancer	0.00041	0.00356	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.00041	0.00356	CcSEcCtD
Podofilox—Dermatitis bullous—Capecitabine—kidney cancer	0.000402	0.00349	CcSEcCtD
Podofilox—Skin disorder—Everolimus—kidney cancer	0.000398	0.00346	CcSEcCtD
Podofilox—Erythema—Dactinomycin—kidney cancer	0.000397	0.00345	CcSEcCtD
Podofilox—Oedema—Erlotinib—kidney cancer	0.000396	0.00344	CcSEcCtD
Podofilox—Pruritus—Temsirolimus—kidney cancer	0.00039	0.00339	CcSEcCtD
Podofilox—Haemoglobin—Gemcitabine—kidney cancer	0.000389	0.00338	CcSEcCtD
Podofilox—Haemorrhage—Gemcitabine—kidney cancer	0.000387	0.00336	CcSEcCtD
Podofilox—Skin disorder—Erlotinib—kidney cancer	0.000384	0.00334	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—kidney cancer	0.000378	0.00328	CcSEcCtD
Podofilox—Insomnia—Everolimus—kidney cancer	0.000371	0.00322	CcSEcCtD
Podofilox—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.00037	0.0627	CbGdCrCtD
Podofilox—Paraesthesia—Vinblastine—kidney cancer	0.00037	0.00321	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000369	0.0032	CcSEcCtD
Podofilox—Paraesthesia—Everolimus—kidney cancer	0.000368	0.0032	CcSEcCtD
Podofilox—Pruritus—Pazopanib—kidney cancer	0.000368	0.00319	CcSEcCtD
Podofilox—Dizziness—Temsirolimus—kidney cancer	0.000365	0.00317	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—kidney cancer	0.000361	0.00313	CcSEcCtD
Podofilox—Insomnia—Erlotinib—kidney cancer	0.000358	0.00311	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000355	0.00308	CcSEcCtD
Podofilox—Dry skin—Capecitabine—kidney cancer	0.000352	0.00306	CcSEcCtD
Podofilox—Pain—Vinblastine—kidney cancer	0.000352	0.00306	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—kidney cancer	0.000352	0.00306	CcSEcCtD
Podofilox—Pain—Everolimus—kidney cancer	0.000351	0.00305	CcSEcCtD
Podofilox—Vomiting—Temsirolimus—kidney cancer	0.000351	0.00305	CcSEcCtD
Podofilox—Immune system disorder—Gemcitabine—kidney cancer	0.00035	0.00304	CcSEcCtD
Podofilox—Rash—Temsirolimus—kidney cancer	0.000348	0.00302	CcSEcCtD
Podofilox—Dermatitis—Temsirolimus—kidney cancer	0.000347	0.00302	CcSEcCtD
Podofilox—Skin disorder—Sorafenib—kidney cancer	0.000346	0.003	CcSEcCtD
Podofilox—Headache—Temsirolimus—kidney cancer	0.000345	0.003	CcSEcCtD
Podofilox—Haematuria—Paclitaxel—kidney cancer	0.000344	0.00299	CcSEcCtD
Podofilox—Dizziness—Pazopanib—kidney cancer	0.000344	0.00298	CcSEcCtD
Podofilox—Oedema—Sunitinib—kidney cancer	0.000343	0.00298	CcSEcCtD
Podofilox—Pain—Erlotinib—kidney cancer	0.000338	0.00294	CcSEcCtD
Podofilox—Erythema—Gemcitabine—kidney cancer	0.000337	0.00293	CcSEcCtD
Podofilox—Skin disorder—Sunitinib—kidney cancer	0.000333	0.00289	CcSEcCtD
Podofilox—Vomiting—Pazopanib—kidney cancer	0.00033	0.00287	CcSEcCtD
Podofilox—Rash—Pazopanib—kidney cancer	0.000328	0.00284	CcSEcCtD
Podofilox—Dermatitis—Pazopanib—kidney cancer	0.000327	0.00284	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—kidney cancer	0.000326	0.00283	CcSEcCtD
Podofilox—Haemoglobin—Paclitaxel—kidney cancer	0.000326	0.00283	CcSEcCtD
Podofilox—Headache—Pazopanib—kidney cancer	0.000325	0.00283	CcSEcCtD
Podofilox—Oedema—Dactinomycin—kidney cancer	0.000324	0.00282	CcSEcCtD
Podofilox—Haemorrhage—Paclitaxel—kidney cancer	0.000324	0.00281	CcSEcCtD
Podofilox—Insomnia—Sunitinib—kidney cancer	0.00031	0.00269	CcSEcCtD
Podofilox—Paraesthesia—Sunitinib—kidney cancer	0.000308	0.00267	CcSEcCtD
Podofilox—Pain—Sorafenib—kidney cancer	0.000305	0.00264	CcSEcCtD
Podofilox—Pain—Sunitinib—kidney cancer	0.000293	0.00254	CcSEcCtD
Podofilox—Immune system disorder—Paclitaxel—kidney cancer	0.000293	0.00254	CcSEcCtD
Podofilox—Pruritus—Everolimus—kidney cancer	0.00029	0.00252	CcSEcCtD
Podofilox—Oedema—Vincristine—kidney cancer	0.00029	0.00252	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000285	0.00247	CcSEcCtD
Podofilox—Haematuria—Capecitabine—kidney cancer	0.000282	0.00245	CcSEcCtD
Podofilox—Erythema—Paclitaxel—kidney cancer	0.000282	0.00245	CcSEcCtD
Podofilox—Pruritus—Erlotinib—kidney cancer	0.00028	0.00243	CcSEcCtD
Podofilox—Pain—Dactinomycin—kidney cancer	0.000277	0.00241	CcSEcCtD
Podofilox—Oedema—Gemcitabine—kidney cancer	0.000275	0.00239	CcSEcCtD
Podofilox—Dizziness—Vinblastine—kidney cancer	0.000272	0.00236	CcSEcCtD
Podofilox—Dizziness—Everolimus—kidney cancer	0.000271	0.00236	CcSEcCtD
Podofilox—Haemoglobin—Capecitabine—kidney cancer	0.000267	0.00232	CcSEcCtD
Podofilox—Skin disorder—Gemcitabine—kidney cancer	0.000267	0.00232	CcSEcCtD
Podofilox—Haemorrhage—Capecitabine—kidney cancer	0.000266	0.00231	CcSEcCtD
Podofilox—Insomnia—Vincristine—kidney cancer	0.000262	0.00228	CcSEcCtD
Podofilox—Vomiting—Vinblastine—kidney cancer	0.000262	0.00227	CcSEcCtD
Podofilox—Dizziness—Erlotinib—kidney cancer	0.000262	0.00227	CcSEcCtD
Podofilox—Vomiting—Everolimus—kidney cancer	0.000261	0.00227	CcSEcCtD
Podofilox—Paraesthesia—Vincristine—kidney cancer	0.00026	0.00226	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—kidney cancer	0.000259	0.00225	CcSEcCtD
Podofilox—Rash—Everolimus—kidney cancer	0.000259	0.00225	CcSEcCtD
Podofilox—Dermatitis—Everolimus—kidney cancer	0.000258	0.00224	CcSEcCtD
Podofilox—Headache—Vinblastine—kidney cancer	0.000258	0.00224	CcSEcCtD
Podofilox—Headache—Everolimus—kidney cancer	0.000257	0.00223	CcSEcCtD
Podofilox—Pruritus—Sorafenib—kidney cancer	0.000252	0.00219	CcSEcCtD
Podofilox—Vomiting—Erlotinib—kidney cancer	0.000252	0.00219	CcSEcCtD
Podofilox—Rash—Erlotinib—kidney cancer	0.00025	0.00217	CcSEcCtD
Podofilox—Dermatitis—Erlotinib—kidney cancer	0.000249	0.00217	CcSEcCtD
Podofilox—Insomnia—Gemcitabine—kidney cancer	0.000249	0.00216	CcSEcCtD
Podofilox—Headache—Erlotinib—kidney cancer	0.000248	0.00215	CcSEcCtD
Podofilox—Pain—Vincristine—kidney cancer	0.000248	0.00215	CcSEcCtD
Podofilox—Paraesthesia—Gemcitabine—kidney cancer	0.000247	0.00214	CcSEcCtD
Podofilox—Pruritus—Sunitinib—kidney cancer	0.000242	0.00211	CcSEcCtD
Podofilox—Immune system disorder—Capecitabine—kidney cancer	0.00024	0.00209	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000238	0.00207	CcSEcCtD
Podofilox—Dizziness—Sorafenib—kidney cancer	0.000235	0.00204	CcSEcCtD
Podofilox—Pain—Gemcitabine—kidney cancer	0.000235	0.00204	CcSEcCtD
Podofilox—Erythema—Capecitabine—kidney cancer	0.000231	0.00201	CcSEcCtD
Podofilox—Oedema—Paclitaxel—kidney cancer	0.00023	0.002	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—kidney cancer	0.000227	0.00197	CcSEcCtD
Podofilox—Dizziness—Sunitinib—kidney cancer	0.000227	0.00197	CcSEcCtD
Podofilox—Vomiting—Sorafenib—kidney cancer	0.000226	0.00197	CcSEcCtD
Podofilox—Rash—Sorafenib—kidney cancer	0.000225	0.00195	CcSEcCtD
Podofilox—Dermatitis—Sorafenib—kidney cancer	0.000224	0.00195	CcSEcCtD
Podofilox—Skin disorder—Paclitaxel—kidney cancer	0.000224	0.00194	CcSEcCtD
Podofilox—Headache—Sorafenib—kidney cancer	0.000223	0.00194	CcSEcCtD
Podofilox—Vomiting—Sunitinib—kidney cancer	0.000218	0.00189	CcSEcCtD
Podofilox—Rash—Sunitinib—kidney cancer	0.000216	0.00188	CcSEcCtD
Podofilox—Dermatitis—Sunitinib—kidney cancer	0.000216	0.00187	CcSEcCtD
Podofilox—Headache—Sunitinib—kidney cancer	0.000215	0.00186	CcSEcCtD
Podofilox—Insomnia—Paclitaxel—kidney cancer	0.000208	0.00181	CcSEcCtD
Podofilox—Paraesthesia—Paclitaxel—kidney cancer	0.000207	0.0018	CcSEcCtD
Podofilox—Vomiting—Dactinomycin—kidney cancer	0.000206	0.00179	CcSEcCtD
Podofilox—Rash—Dactinomycin—kidney cancer	0.000205	0.00178	CcSEcCtD
Podofilox—Pain—Paclitaxel—kidney cancer	0.000197	0.00171	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000196	0.0017	CcSEcCtD
Podofilox—Pruritus—Gemcitabine—kidney cancer	0.000195	0.00169	CcSEcCtD
Podofilox—Dizziness—Vincristine—kidney cancer	0.000192	0.00166	CcSEcCtD
Podofilox—Oedema—Capecitabine—kidney cancer	0.000189	0.00164	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000188	0.0319	CbGdCrCtD
Podofilox—TOP2A—Vindesine—Vincristine—kidney cancer	0.000188	0.0319	CbGdCrCtD
Podofilox—Vomiting—Vincristine—kidney cancer	0.000184	0.0016	CcSEcCtD
Podofilox—Skin disorder—Capecitabine—kidney cancer	0.000183	0.00159	CcSEcCtD
Podofilox—TUBB—Azacitidine—Gemcitabine—kidney cancer	0.000183	0.031	CbGdCrCtD
Podofilox—Rash—Vincristine—kidney cancer	0.000183	0.00159	CcSEcCtD
Podofilox—Dermatitis—Vincristine—kidney cancer	0.000183	0.00159	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—kidney cancer	0.000182	0.00158	CcSEcCtD
Podofilox—Headache—Vincristine—kidney cancer	0.000182	0.00158	CcSEcCtD
Podofilox—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000177	0.03	CbGdCrCtD
Podofilox—Vomiting—Gemcitabine—kidney cancer	0.000175	0.00152	CcSEcCtD
Podofilox—Rash—Gemcitabine—kidney cancer	0.000173	0.00151	CcSEcCtD
Podofilox—Dermatitis—Gemcitabine—kidney cancer	0.000173	0.0015	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—kidney cancer	0.000172	0.0015	CcSEcCtD
Podofilox—Headache—Gemcitabine—kidney cancer	0.000172	0.0015	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—kidney cancer	0.000171	0.00149	CcSEcCtD
Podofilox—Insomnia—Capecitabine—kidney cancer	0.000171	0.00148	CcSEcCtD
Podofilox—Paraesthesia—Capecitabine—kidney cancer	0.00017	0.00147	CcSEcCtD
Podofilox—Pruritus—Paclitaxel—kidney cancer	0.000163	0.00141	CcSEcCtD
Podofilox—Pain—Capecitabine—kidney cancer	0.000162	0.0014	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—kidney cancer	0.000155	0.00134	CcSEcCtD
Podofilox—Dizziness—Paclitaxel—kidney cancer	0.000152	0.00132	CcSEcCtD
Podofilox—Erythema—Doxorubicin—kidney cancer	0.000149	0.0013	CcSEcCtD
Podofilox—Vomiting—Paclitaxel—kidney cancer	0.000146	0.00127	CcSEcCtD
Podofilox—Rash—Paclitaxel—kidney cancer	0.000145	0.00126	CcSEcCtD
Podofilox—Dermatitis—Paclitaxel—kidney cancer	0.000145	0.00126	CcSEcCtD
Podofilox—Headache—Paclitaxel—kidney cancer	0.000144	0.00125	CcSEcCtD
Podofilox—Pruritus—Capecitabine—kidney cancer	0.000134	0.00116	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000126	0.0011	CcSEcCtD
Podofilox—Dizziness—Capecitabine—kidney cancer	0.000125	0.00108	CcSEcCtD
Podofilox—Oedema—Doxorubicin—kidney cancer	0.000122	0.00106	CcSEcCtD
Podofilox—Vomiting—Capecitabine—kidney cancer	0.00012	0.00104	CcSEcCtD
Podofilox—Rash—Capecitabine—kidney cancer	0.000119	0.00103	CcSEcCtD
Podofilox—Dermatitis—Capecitabine—kidney cancer	0.000119	0.00103	CcSEcCtD
Podofilox—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000119	0.0201	CbGdCrCtD
Podofilox—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000119	0.0201	CbGdCrCtD
Podofilox—Headache—Capecitabine—kidney cancer	0.000118	0.00103	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—kidney cancer	0.000118	0.00103	CcSEcCtD
Podofilox—Insomnia—Doxorubicin—kidney cancer	0.00011	0.000956	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—kidney cancer	0.000109	0.00095	CcSEcCtD
Podofilox—Pain—Doxorubicin—kidney cancer	0.000104	0.000904	CcSEcCtD
Podofilox—TOP2A—Vincristine—Vinblastine—kidney cancer	0.000102	0.0172	CbGdCrCtD
Podofilox—TUBA4A—Hemostasis—IGF2—kidney cancer	9.13e-05	0.00187	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.03e-05	0.00185	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.91e-05	0.00182	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	8.9e-05	0.00182	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IL2—kidney cancer	8.74e-05	0.00179	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BRCA2—kidney cancer	8.66e-05	0.00177	CbGpPWpGaD
Podofilox—Pruritus—Doxorubicin—kidney cancer	8.62e-05	0.000748	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—CDKN2B—kidney cancer	8.58e-05	0.00176	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	8.57e-05	0.00175	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	8.3e-05	0.0017	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—BIRC5—kidney cancer	8.28e-05	0.00169	CbGpPWpGaD
Podofilox—TOP2A—Vinblastine—Vincristine—kidney cancer	8.17e-05	0.0138	CbGdCrCtD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	8.17e-05	0.00167	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2B—kidney cancer	8.16e-05	0.00167	CbGpPWpGaD
Podofilox—Dizziness—Doxorubicin—kidney cancer	8.05e-05	0.000699	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	7.99e-05	0.00164	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HARS—kidney cancer	7.99e-05	0.00164	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	7.9e-05	0.00162	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	7.88e-05	0.00161	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—HIF1A—kidney cancer	7.86e-05	0.00161	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	7.82e-05	0.0016	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PSMD7—kidney cancer	7.81e-05	0.0016	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	7.79e-05	0.00159	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	7.78e-05	0.00159	CbGpPWpGaD
Podofilox—Vomiting—Doxorubicin—kidney cancer	7.74e-05	0.000672	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	7.72e-05	0.00158	CbGpPWpGaD
Podofilox—Rash—Doxorubicin—kidney cancer	7.68e-05	0.000667	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—kidney cancer	7.67e-05	0.000666	CcSEcCtD
Podofilox—Headache—Doxorubicin—kidney cancer	7.63e-05	0.000662	CcSEcCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—AURKA—kidney cancer	7.6e-05	0.00155	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	7.52e-05	0.00154	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND1—kidney cancer	7.52e-05	0.00154	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	7.43e-05	0.00152	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BIRC5—kidney cancer	7.4e-05	0.00152	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BRCA2—kidney cancer	7.36e-05	0.00151	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.32e-05	0.0015	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2B—kidney cancer	7.3e-05	0.00149	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF2—kidney cancer	7.18e-05	0.00147	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	7.04e-05	0.00144	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—BIRC5—kidney cancer	7.04e-05	0.00144	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	7.04e-05	0.00144	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	7.03e-05	0.00144	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PSMD7—kidney cancer	6.98e-05	0.00143	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	6.92e-05	0.00142	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	6.85e-05	0.0014	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	6.83e-05	0.0014	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EIF5B—kidney cancer	6.8e-05	0.00139	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—AURKA—kidney cancer	6.79e-05	0.00139	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	6.79e-05	0.00139	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.73e-05	0.00138	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	6.72e-05	0.00137	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	6.69e-05	0.00137	CbGpPWpGaD
Podofilox—TOP2A—Cytarabine—Gemcitabine—kidney cancer	6.68e-05	0.0113	CbGdCrCtD
Podofilox—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	6.59e-05	0.00135	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	6.52e-05	0.00133	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	6.45e-05	0.00132	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTT1—kidney cancer	6.44e-05	0.00132	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.3e-05	0.00129	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BIRC5—kidney cancer	6.3e-05	0.00129	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	6.25e-05	0.00128	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	6.21e-05	0.00127	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—PTGS1—kidney cancer	6.03e-05	0.00124	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—kidney cancer	6.03e-05	0.00123	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	5.97e-05	0.00122	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	5.8e-05	0.00119	CbGpPWpGaD
Podofilox—TOP2A—Idarubicin—Doxorubicin—kidney cancer	5.73e-05	0.0097	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	5.73e-05	0.0097	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—kidney cancer	5.73e-05	0.0097	CbGdCrCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	5.71e-05	0.00117	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	5.7e-05	0.00117	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	5.68e-05	0.00116	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	5.66e-05	0.00116	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	5.64e-05	0.00115	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	5.56e-05	0.00114	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.5e-05	0.00113	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	5.49e-05	0.00112	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.46e-05	0.00112	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—JUN—kidney cancer	5.46e-05	0.00112	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.43e-05	0.00111	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	5.39e-05	0.0011	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	5.36e-05	0.0011	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.32e-05	0.00109	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PTEN—kidney cancer	5.28e-05	0.00108	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BRCA2—kidney cancer	5.15e-05	0.00105	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	5.13e-05	0.00105	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2B—kidney cancer	5.1e-05	0.00104	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—RAF1—kidney cancer	5.03e-05	0.00103	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	4.97e-05	0.00102	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	4.92e-05	0.00101	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—kidney cancer	4.91e-05	0.001	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	4.86e-05	0.000995	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—POMC—kidney cancer	4.79e-05	0.000981	CbGpPWpGaD
Podofilox—TOP2A—Azacitidine—Gemcitabine—kidney cancer	4.79e-05	0.0081	CbGdCrCtD
Podofilox—NR3C1—Adipogenesis—CTNNB1—kidney cancer	4.7e-05	0.000963	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	4.7e-05	0.000961	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—kidney cancer	4.67e-05	0.000955	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—kidney cancer	4.64e-05	0.000949	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.57e-05	0.000935	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	4.52e-05	0.000926	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—kidney cancer	4.51e-05	0.000922	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.47e-05	0.000915	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTP1—kidney cancer	4.46e-05	0.000914	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	4.41e-05	0.000902	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BIRC5—kidney cancer	4.4e-05	0.000901	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	4.4e-05	0.000901	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.4e-05	0.000901	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EEF2—kidney cancer	4.38e-05	0.000896	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1B—kidney cancer	4.35e-05	0.000889	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.22e-05	0.000864	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—TET2—kidney cancer	4.2e-05	0.000859	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—kidney cancer	4.17e-05	0.000854	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—kidney cancer	4.15e-05	0.000849	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1B—kidney cancer	4.13e-05	0.000846	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—kidney cancer	4.1e-05	0.00084	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	4.1e-05	0.000838	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	4.06e-05	0.000832	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.05e-05	0.000829	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	4.05e-05	0.000828	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—kidney cancer	3.94e-05	0.000807	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	3.89e-05	0.000796	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.88e-05	0.000794	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.87e-05	0.000793	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—TCEB2—kidney cancer	3.84e-05	0.000786	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—TCEB1—kidney cancer	3.84e-05	0.000786	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	3.83e-05	0.000785	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—kidney cancer	3.83e-05	0.000784	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK3—kidney cancer	3.82e-05	0.000783	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.75e-05	0.000768	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—kidney cancer	3.72e-05	0.000761	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1B—kidney cancer	3.69e-05	0.000756	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK1—kidney cancer	3.64e-05	0.000745	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.63e-05	0.000743	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK3—kidney cancer	3.62e-05	0.000742	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—kidney cancer	3.6e-05	0.000737	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	3.59e-05	0.000735	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.58e-05	0.000732	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—kidney cancer	3.52e-05	0.000721	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK1—kidney cancer	3.45e-05	0.000706	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—kidney cancer	3.42e-05	0.0007	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACY1—kidney cancer	3.42e-05	0.0007	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK3—kidney cancer	3.42e-05	0.0007	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—kidney cancer	3.33e-05	0.000681	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.28e-05	0.000672	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	3.26e-05	0.000668	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—kidney cancer	3.26e-05	0.000666	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK1—kidney cancer	3.25e-05	0.000666	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK3—kidney cancer	3.25e-05	0.000665	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—kidney cancer	3.16e-05	0.000647	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPL14—kidney cancer	3.12e-05	0.000639	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK1—kidney cancer	3.09e-05	0.000633	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—kidney cancer	2.99e-05	0.000612	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—kidney cancer	2.92e-05	0.000597	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.92e-05	0.000597	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PDHB—kidney cancer	2.91e-05	0.000595	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK3—kidney cancer	2.91e-05	0.000595	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—POMC—kidney cancer	2.9e-05	0.000593	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—kidney cancer	2.89e-05	0.000592	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	2.89e-05	0.000592	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—kidney cancer	2.83e-05	0.000579	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK1—kidney cancer	2.77e-05	0.000566	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	2.76e-05	0.000564	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CCBL1—kidney cancer	2.73e-05	0.00056	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—kidney cancer	2.73e-05	0.000559	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.68e-05	0.000549	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.65e-05	0.000542	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—kidney cancer	2.58e-05	0.000529	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	2.54e-05	0.000521	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPB1—kidney cancer	2.54e-05	0.000521	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.47e-05	0.000506	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.47e-05	0.000505	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—kidney cancer	2.47e-05	0.000505	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.43e-05	0.000498	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPAT—kidney cancer	2.37e-05	0.000485	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.37e-05	0.000485	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSMD7—kidney cancer	2.36e-05	0.000484	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.34e-05	0.000479	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.34e-05	0.000479	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—kidney cancer	2.32e-05	0.000475	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.32e-05	0.000474	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.31e-05	0.000472	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.27e-05	0.000465	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	2.21e-05	0.000453	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FH—kidney cancer	2.2e-05	0.000451	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APRT—kidney cancer	2.2e-05	0.000451	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.16e-05	0.000443	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.15e-05	0.000441	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—JUNB—kidney cancer	2.12e-05	0.000435	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPC3—kidney cancer	2.07e-05	0.000424	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACY1—kidney cancer	2.06e-05	0.000421	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—kidney cancer	2.03e-05	0.000416	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA2—kidney cancer	2.02e-05	0.000413	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—kidney cancer	1.98e-05	0.000405	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALAD—kidney cancer	1.96e-05	0.000402	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK1—kidney cancer	1.93e-05	0.000396	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.92e-05	0.000392	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.87e-05	0.000384	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PGK1—kidney cancer	1.8e-05	0.000368	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.8e-05	0.000368	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LDHB—kidney cancer	1.76e-05	0.000361	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PDHB—kidney cancer	1.75e-05	0.000358	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—POMC—kidney cancer	1.74e-05	0.000357	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.73e-05	0.000354	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CCBL1—kidney cancer	1.64e-05	0.000337	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—kidney cancer	1.62e-05	0.000332	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA9—kidney cancer	1.53e-05	0.000313	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.49e-05	0.000306	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.43e-05	0.000292	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPAT—kidney cancer	1.43e-05	0.000292	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.39e-05	0.000285	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FH—kidney cancer	1.33e-05	0.000271	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APRT—kidney cancer	1.33e-05	0.000271	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CRABP1—kidney cancer	1.3e-05	0.000266	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPC3—kidney cancer	1.25e-05	0.000255	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA2—kidney cancer	1.21e-05	0.000248	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ITPR2—kidney cancer	1.21e-05	0.000247	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALAD—kidney cancer	1.18e-05	0.000242	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.15e-05	0.000236	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.13e-05	0.000231	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.11e-05	0.000228	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACHE—kidney cancer	1.1e-05	0.000225	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—kidney cancer	1.1e-05	0.000225	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.08e-05	0.000221	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PGK1—kidney cancer	1.08e-05	0.000221	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LDHB—kidney cancer	1.06e-05	0.000217	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SCARB1—kidney cancer	1.04e-05	0.000213	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS1—kidney cancer	1.03e-05	0.000211	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSMD7—kidney cancer	1.01e-05	0.000207	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BCHE—kidney cancer	9.59e-06	0.000196	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A5—kidney cancer	9.48e-06	0.000194	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA9—kidney cancer	9.19e-06	0.000188	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A1—kidney cancer	9.15e-06	0.000187	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.88e-06	0.000182	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CRABP1—kidney cancer	7.81e-06	0.00016	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.74e-06	0.000159	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—kidney cancer	7.63e-06	0.000156	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ITPR2—kidney cancer	7.26e-06	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—kidney cancer	7.23e-06	0.000148	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—kidney cancer	7.01e-06	0.000144	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—kidney cancer	6.89e-06	0.000141	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—kidney cancer	6.7e-06	0.000137	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A1—kidney cancer	6.65e-06	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACHE—kidney cancer	6.62e-06	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—kidney cancer	6.62e-06	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SCARB1—kidney cancer	6.27e-06	0.000128	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS1—kidney cancer	6.21e-06	0.000127	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSMD7—kidney cancer	6.09e-06	0.000125	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BCHE—kidney cancer	5.77e-06	0.000118	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.7e-06	0.000117	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.5e-06	0.000113	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.46e-06	0.000112	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—POMC—kidney cancer	4.96e-06	0.000101	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—kidney cancer	4.59e-06	9.4e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—kidney cancer	4.35e-06	8.89e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—kidney cancer	4.22e-06	8.63e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A1—kidney cancer	4e-06	8.18e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—kidney cancer	3.95e-06	8.09e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—kidney cancer	3.45e-06	7.06e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—POMC—kidney cancer	2.98e-06	6.1e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.43e-06	4.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—kidney cancer	2.38e-06	4.87e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—kidney cancer	2.07e-06	4.24e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.46e-06	2.99e-05	CbGpPWpGaD
